These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14470881)

  • 21. Roentgen treatment of myeloma with special consideration to the dosage.
    NORIN T
    Acta Radiol (Stockh); 1957 Jan; 47(1):46-54. PubMed ID: 13402542
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paradoxical association of myelomatous osteolysis with intense hyperosteoidosis. Inverse sensitivity to vitamin D and prednisone].
    LICHTWITZ A; de SEZE ; HIOCO D; BORDIER P; MAZABRAUD A
    Sem Hop; 1960 Apr; 36():1271-7. PubMed ID: 14416768
    [No Abstract]   [Full Text] [Related]  

  • 23. Urethane in multiple myeloma. I. Final report of a case treated more than four years with urethane.
    ALWALL N
    Acta Med Scand; 1952; 144(2):114-18. PubMed ID: 13007417
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    BERGSAGEL DE; ROSS SW; BAKER DT
    Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of successful treatment with sarcolysin of a patient with myeloma].
    BAISOGOLOV GD; DOSHCHENKO VN; CHIZH AS
    Probl Gematol Pereliv Krovi; 1961 Aug; 6():51-4. PubMed ID: 13864079
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period.
    LUTTGENS WF; BAYRD ED
    J Am Med Assoc; 1951 Oct; 147(9):824-7. PubMed ID: 14873565
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980).
    BERGSAGEL DE; ROSS SW; DAVIS P
    Cancer Chemother Rep; 1962 Aug; 21():75-80. PubMed ID: 13867793
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of patients with plasmocytoma].
    SANDKUHLER S
    Medizinische; 1956 Nov; 24(45):1601-3. PubMed ID: 13377999
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kahler's disease improved by cortisone].
    COSTE F; DELBARRE F; URO
    Rev Rhum Mal Osteoartic; 1952 Apr; 19(4):348-50. PubMed ID: 14958340
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin.
    KRISS JP; BIERMAN HR; THOMAS SF; NEWELL RR
    Radiology; 1955 Aug; 65(2):241-9. PubMed ID: 13245970
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of M and B 938 in myelomatosis.
    WARD HW
    J Fac Radiol; 1958 Oct; 9(4):221-2. PubMed ID: 24544992
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    BERGSAGEL DE
    Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796
    [No Abstract]   [Full Text] [Related]  

  • 35. Diamidines in myelomatosis.
    BICHEL J
    Acta Radiol (Stockh); 1952 Jan; 37(1):65-73. PubMed ID: 14902604
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of malignant systemic diseases].
    VIDEBAEK A
    Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805
    [No Abstract]   [Full Text] [Related]  

  • 37. On the effect of corticotropin (ACTH) on myelomatosis with special reference to the bone marrow and the serum proteins.
    Effersøe P; Gormsen H; Harboe N; Nielsen SE; Videbaek AA
    Acta Med Scand; 1952 May; 143(1):63-82. PubMed ID: 12976012
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of plasmocytoma and macroglobulinemia].
    DI GUGLIELMO R
    Schweiz Med Wochenschr; 1960 Oct; 90():1189-93. PubMed ID: 13722506
    [No Abstract]   [Full Text] [Related]  

  • 39. Urethane-induced hepatic failure in man.
    WEISS DL; DE LOS SANTOS R
    Am J Med; 1960 Mar; 28():476-81. PubMed ID: 13843702
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of combination 5-fluorouracil and supervoltage irradiation therapy in advanced carcinoma of the urinary bladder--a preliminary report.
    WOODRUFF MW; MURPHY WT; HODSON JM
    Cancer Chemother Rep; 1962 Aug; 21():123-7. PubMed ID: 14008235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.